Sarepta Therapeutics
SRPT
#1535
Rank
C$15.97 B
Marketcap
$167.26
Share price
-5.90%
Change (1 day)
46.49%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

P/S ratio for Sarepta Therapeutics (SRPT)

P/S ratio as of November 2024 (TTM): 7.64

According to Sarepta Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.7. At the end of 2024 the company had a P/S ratio of 9.92.

P/S ratio history for Sarepta Therapeutics from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20249.9236.78%
20237.26-40.49%
202212.29.13%
202111.2-55.15%
202024.9-2.22%
201925.5-1.12%
201825.810.75%
201723.3-91.58%
2016276-80.34%
2015> 10002193.16%
201461.313.28%
201354.1146.82%
201221.9918.16%
20112.15-73.42%
20108.10-11.73%
20099.17316.41%
20082.20-73.37%
20078.27-99.44%
2006> 10003874.02%
200536.9-81.29%
200419736.42%
2003145-8.87%
2002159-55.81%
2001359

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.39-42.59%๐Ÿ‡บ๐Ÿ‡ธ USA
1.87-75.50%๐Ÿ‡บ๐Ÿ‡ธ USA
530 6,833.48%๐Ÿ‡บ๐Ÿ‡ธ USA
4.16-45.62%๐Ÿ‡บ๐Ÿ‡ธ USA
16.8 119.31%๐Ÿ‡บ๐Ÿ‡ธ USA
3.67-51.98%๐Ÿ‡บ๐Ÿ‡ธ USA
37.4 389.30%๐Ÿ‡บ๐Ÿ‡ธ USA